Identification and validation of biomarkers of cervicovaginal mucosal alteration

Information

• Research Project
• 8348551

• ApplicationId

  8348551

• Core Project Number

  Y1AI1756-1-0-1

• Full Project Number

  Y1AI1756-1-0-1

• Serial Number

  1756

• FOA Number

• Sub Project Id

• Project Start Date

  -

• Project End Date

  -

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2011

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• National Institute of Allergy and Infectious Diseases (NIAID)

The purpose of this Interagency Agreement, hereafter "Agreement," is to provide funding by the National Institute of Allergy and Infectious Diseases (NIAID) to the United States Agency for International Development (USAID) for the purpose of providing support to HIV prevention research in order to reduce the transmission of human immunodeficiency virus (HIV), and recognize the potential utility of topical microbicides and other non-vaccine biomedical prevention (TM/BP) methods in affecting the global HIV IAIDS epidemic.

IC Name

• Activity

  Y01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  2200000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:2200000\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

• Organization Department

• Organization DUNS

• Organization City

• Organization State

• Organization Country

• Organization Zip Code

• Organization District